Table 2.
Disease and treatment characteristics of patients with cancer treated with systemic therapy in Rwanda (n = 239) during 2022.
| Disease site | N (%) |
| Breast | 100 (42) |
| Colorectal | 57(24) |
| Cervical | 58(24) |
| Hodgkin’s lymphoma | 13(5) |
| Non-Hodgkin’s lymphoma | 11(5) |
| Stage of the disease | N (%) |
| Stage I | 5(2) |
| Stage II | 36(15) |
| Stage III | 92(39) |
| Stage IV | 37(16) |
| Not mentioned | 63(26) |
| Missing | 6(3) |
| Treatment setting/intent | N (%) |
| Neo adjuvant | 57(24) |
| Adjuvant | 98(41) |
| Palliative | 59(25) |
| Definitive (eg, lymphoma) | 12(5) |
| Temporalizing chemo (eg, Cervix, NPC) | 4(2) |
| Missing | 9(4) |